Darzalex 20 mg/ml concentrate for solution for infusion


Concentrate for solution for infusion
scheduling status
S4
registration number
51/26/0329
What Darzalex 20 mg/ml concentrate for solution for infusion contains
Daratumumab.
other ingredients
Glacial acetic acid, mannitol (E421), polysorbate 20, sodium acetate trihydrate, sodium chloride and water for injection.
Therapeutic classification
A 26 Cytostatic agents (L01FC01).
© 2026 SAHPRA. ALL RIGHTS RESERVED